Search results
Added:
4 months ago
Source:
Radcliffe CVRM
The glucagon-like peptide 1 (GLP-1) receptor agonist liraglutide did not meet its primary endpoint for changing cerebral glucose metabolism but did show a beneficial effect on a secondary cognitive outcome in patients with mild to moderate Alzheimer's disease (AD), according to results from the phase 2b ELAD trial.¹Liraglutide is a GLP-1 receptor agonist approved for the treatment of type 2…
View more
Eva Gerdts
Research Area(s) / Expertise:
Job title: Chief of the Non-invasive Cardiac Imaging Unit
Author
Fozia Ahmed
Research Area(s) / Expertise:
Job title: Consultant Cardiologist (Sub-specialty interests in Heart Failure and Cardiac Devices)
Author
Andrew Frankel
Research Area(s) / Expertise:
Job title: Consultant Nephrologist
Author
Author(s):
Nils Krüger
Added:
5 months ago
AHA Scientific Sessions 2025 - Dr Nils Krüger (Brigham and Women's Hospital, US) joins us to discuss findings from the TIRZSEMA-CVOT (NCT07096063) study, examining real-world cardiovascular outcomes with tirzepatide and semaglutide in patients with type 2 diabetes at cardiovascular risk.This retrospective cohort study utilized three national US claims databases to evaluate over 887,000 patients…
View more
Added:
9 months ago
Source:
Radcliffe CVRM
Five classic risk factors are responsible for about half of the global cardiovascular disease (CVD) burden. A major new analysis from the Global Cardiovascular Risk Consortium, published in the New England Journal of Medicine, has quantified the profound impact of these factors on lifetime estimates of CVD and all-cause mortality, revealing that their absence at midlife is associated with more…
View more
Francisco Lopez-Jimenez
Job title: Director of the Cardiometabolic Program
Author
ERA Congress 2025 Late-Breaking Collection
Video Series
Link Between NAFLD/NASH and Cardiometabolic Syndrome
Author(s):
Sheila Gato
,
Vanessa García-Fernández
,
Antonio Gil-Gómez
,
et al
Added:
1 year ago
Review Article
Treatment Options and Continuity of Care in MAFLD
Author(s):
Carmen Lara-Romero
,
Manuel Romero-Gómez
Added:
1 year ago
Review Article